EUVIMEDEUVIMED entdecken
Scoping ReviewStudienprotokollOpen Access · CC BY-NC 4.0

Translational Research on Polygenic Risk Scores in Common Neurodegenerative Diseases - A Scoping Review Protocol

Mojca Čižek Sajko, Jana Suklan, Džanan Osmanović, Borut Peterlin

Acta Medica Academica · 2025

DOI: 10.5644/ama2006-124.463 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Acta Medica Academica, 2025. Verfasst von Mojca Čižek Sajko und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Institute for Genomic Medicine, University Medical Centre Ljubljana, Slovenia. mojca.cizek.sajko@kclj.si. Hauptthemen laut MEDLINE: Genetic Risk Score, Multifactorial Inheritance, Neurodegenerative Diseases, Translational Research, Biomedical. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The purpose of this protocol is to clearly describe the process for the scoping review we plan to conduct on the topicof polygenic risk scores (PRS) in common neurodegenerative diseases. We will present the review's objective, the strategy forevidence search, the data extraction and analysis procedure, and how the results will be presented.

Methods

The inclusion criteria for the planned scoping review will focus on evidence sources that involve PRS applied to neurogenerative diseases such as Multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and Amyotrophic lateral sclerosis in any phase of translational research, from early development to clinical implementation. This includes its use in risk prediction, early diagnosis, prognosis, and treatment decision-making. The research questions were created based on the population, context, and concept framework. We will consider both peer-reviewed papers and grey literature published in English or German for inclusion. Two independent reviewers will search for information.

Conclusion

The findings from the scoping review will be presented descriptively and summarized according to the research questions to illustrate the current status of translational research on PRS in commonneurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Risk ScoreMultifactorial InheritanceNeurodegenerative DiseasesTranslational Research, BiomedicalHumansAlzheimer DiseaseAmyotrophic Lateral SclerosisGenetic Predisposition to DiseaseMultiple SclerosisParkinson DiseaseResearch DesignRisk AssessmentRisk FactorsScoping Reviews as Topic

Stichwörter der Autor:innen

Evidence GapsGenetic Risk ScoreNervous System Diseases

Autor:innen und Institutionen

  • Clinical Institute for Genomic Medicine, University Medical Centre Ljubljana, Slovenia. mojca.cizek.sajko@kclj.si.
  • National Institute for Health and Care Research (NIHR) HealthTech Research Centre (HRC) in Diagnostic and Technology Evaluation, Newcastle, United Kingdom; Translational and Clinical Research Institute, Faculty of Medic…
  • Faculty of Science and Mathematics, University of Tuzla, Bosnia and Herzegovina.
  • Clinical Institute for Genomic Medicine, University Medical Centre Ljubljana, Slovenia.

Zitieren

APA

Čižek Sajko, M., Suklan, J., Osmanović, D., & Peterlin, B. (2025). Translational Research on Polygenic Risk Scores in Common Neurodegenerative Diseases - A Scoping Review Protocol. Acta Medica Academica. https://doi.org/10.5644/ama2006-124.463

Vancouver

Čižek Sajko M, Suklan J, Osmanović D, Peterlin B. Translational Research on Polygenic Risk Scores in Common Neurodegenerative Diseases - A Scoping Review Protocol. Acta Medica Academica. 2025. doi:10.5644/ama2006-124.463

BibTeX
@article{iekSajko2025,
  author = {Čižek Sajko, Mojca and Suklan, Jana and Osmanović, Džanan and Peterlin, Borut},
  title = {Translational Research on Polygenic Risk Scores in Common Neurodegenerative Diseases - A Scoping Review Protocol},
  journal = {Acta Medica Academica},
  year = {2025},
  doi = {10.5644/ama2006-124.463}
}
Kostenlos starten →